• FITC-Concanavalin A (ConA) Conjugate: Technical Use Guide

  2026-05-06

  FITC-Concanavalin A (ConA) Conjugate enables targeted detection of α-D-glucose and α-D-mannose residues on cell surfaces, supporting immunofluorescence staining and flow cytometry in glycobiology workflows. This reagent should not be used for non-carbohydrate binding assays or outside its defined stability and storage parameters.

• Sulfo-Cy3 Azide: Optimizing Click Chemistry Fluorescent Labe

  2026-05-05

  Sulfo-Cy3 azide delivers robust, photostable, and water-soluble performance for Click Chemistry-based fluorescent labeling in challenging biological systems. Explore advanced workflows, troubleshooting tactics, and unique assay enhancements that empower precise, reproducible imaging of complex neural and cellular architectures.

• Intranasal Epinephrine in Dogs: Pharmacokinetics and Heart R

  2026-05-05

  This study evaluated the pharmacokinetics and cardiovascular impact of intranasal versus intramuscular epinephrine administration in dogs, revealing that intranasal delivery enables rapid epinephrine absorption without excessive heart rate increase. The findings provide a data-driven foundation for alternative epinephrine delivery strategies relevant to translational research in adrenergic signaling and emergency medicine.

• Epinephrine’s Systemic Effects in Local Dental Anesthesia: A

  2026-05-04

  This review critically examines the systemic actions and optimal concentrations of epinephrine as a vasoconstrictor in dental local anesthesia. By dissecting experimental and clinical data, the paper clarifies how epinephrine’s pharmacodynamics influence both efficacy and safety, supporting evidence-based guidelines for dental practice.

• HDAC Inhibitors Enhance Oncolytic HSV Efficacy in Malignant

  2026-05-04

  Kawamura et al. demonstrate that histone deacetylase inhibitors, including Panobinostat (LBH589), significantly enhance the therapeutic effect of oncolytic herpes simplex virus (oHSV) in models of malignant meningioma. Their work reveals mechanistic synergy between epigenetic modulation and virotherapy, providing a promising direction for overcoming therapeutic resistance in this aggressive tumor type.

• Fucoidan in Cancer & Immunology: Applied Workflows and Troub

  2026-05-03

  Fucoidan (APExBIO, C4038) stands out as a high-purity sulfated α-L-fucan enabling advanced cancer, immunology, and liver injury research. This article decodes how to design, optimize, and troubleshoot experiments leveraging Fucoidan’s unique mechanisms and the latest reference breakthroughs.

• N6-Methyl-dATP: Precision Epigenetic Tool for AML Mechanism

  2026-05-02

  Explore how N6-Methyl-dATP advances DNA replication fidelity research and acute myeloid leukemia (AML) mechanism studies. This article uniquely bridges molecular epigenetics and transcriptional regulation, offering new insight for experimental design.

• PreScission Protease: Precision Tag Cleavage for Translation

  2026-05-01

  This thought-leadership article explores the mechanistic precision and strategic utility of PreScission Protease (PSP), a recombinant HRV 3C protease, for translational researchers navigating the complexities of protein purification and advanced functional studies. By integrating new biological insights from nuclear condensate research, we position APExBIO’s PSP as a transformative tool that bridges molecular detail with high-impact applications in biomedicine.

• Hexetidine (NSC-17764): Optimizing Oral Biofilm & Antibacter

  2026-05-01

  Hexetidine (NSC-17764) stands out as a versatile, broad-spectrum antibacterial agent for oral infection models, excelling in both planktonic and biofilm inhibition settings. This guide bridges systematic review insights and laboratory best practices, empowering researchers to maximize reproducibility and interpretability in dental plaque and gingivitis research.

• PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Applied

  2026-04-30

  PYR-41, a potent inhibitor of Ubiquitin-Activating Enzyme E1, enables precise modulation of the ubiquitin-proteasome system, with transformative applications in inflammation, antiviral research, and apoptosis assays. This guide delivers stepwise workflow enhancements and troubleshooting strategies, translating current literature into actionable protocols for bench scientists.

• GPR35-KLF5 Circuitry in DSS-Induced Epithelial Repair

  2026-04-30

  This study reveals how intestinal epithelial cells detect and respond to mucosal injury via the GPR35-KLF5 signaling circuit, which senses tryptophan metabolites and initiates repair in ulcerative colitis models. The findings clarify the molecular logic of repair programming in DSS-induced colitis, informing future approaches to intestinal inflammation research.

• Nocodazole: Microtubule Polymerization Inhibitor for Dynamic

  2026-04-29

  Nocodazole is redefining microtubule dynamics research and cell cycle regulation assays, offering robust, reversible inhibition for reproducible results. Applied workflows leverage its precise action for pathogen entry studies, anticancer drug evaluation, and advanced cytoskeletal interrogation.

• Ultrasound-Enhanced Cu Single-Atom MOFs for Targeted Nanocat

  2026-04-29

  This study presents a copper single-atom-based metal-organic framework (MOF) engineered for ultrasound-enhanced nanocatalytic therapy, demonstrating improved chemodynamic tumor ablation via glutathione depletion and Fenton-like reactive oxygen species generation. The integration of near-infrared fluorescent dye IR-1061 enables precise in vivo imaging and tumor targeting, offering a foundation for more efficient and selective cancer therapeutics.

• BX795: Translating PDK1 Inhibition into Immune and Cancer In

  2026-04-28

  Explore how BX795, a selective PDK1 inhibitor, is redefining translational research at the interface of innate immunity, autophagy, and cancer biology. This thought-leadership article blends mechanistic depth, protocol guidance, and strategic perspectives for researchers navigating the expanding frontiers of kinase signaling and immune modulation.

• Exemestane: Steroidal Aromatase Inhibitor for Precision Assa

  2026-04-28

  Exemestane empowers researchers with robust, irreversible inhibition of cytochrome P450 aromatase, elevating both in vitro and in vivo breast cancer research workflows. Leveraging APExBIO’s high-purity formulation, scientists achieve reproducible estrogen biosynthesis inhibition and streamlined troubleshooting for hormone-dependent cancer assays.

16081 records 1/1073 page Next 12345 下5页 Last page